MO St. Louis의 다발성 골수종 임상 시험
다발성 골수종 관련 연구 26개가 St. Louis 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
피험자 모집 중2상
- Cancer Care Center of O'Fallon, O'Fallon · 16마일 거리
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16마일 거리
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
피험자 모집 중3상
- Washington University School of Medicine in St. Louis, St Louis
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
피험자 모집 중2상
- Washington University School Of Medicine, St Louis
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
피험자 모집 중4상
- Washington University School Of Medicine, St Louis
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중2상
- Washington University School Of Medicine, St Louis
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
피험자 모집 중2상
- Washington University/Siteman Cancer Center, St Louis
Collection of Tissue Samples for Cancer Research
피험자 모집 중관찰 연구
- Washington University - St. Louis, St Louis
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
피험자 모집 중1/2상
- Washington University School of Medicine, St Louis
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
피험자 모집 중3상
- Research Site, St Louis
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중1/2상
- Research Site, St Louis
Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
피험자 모집 중1상
- Washington University School of Medicine, St Louis
Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
피험자 모집 중1상
- Washington University School of Medicine, St Louis
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
피험자 모집 중3상
- Washington University School of Medicine, St Louis
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
피험자 모집 중
- Washington University School of Medicine, St Louis
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중2상
- Washington University School of Medicine, St Louis
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
피험자 모집 중1상
- Research Site, St Louis
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
피험자 모집 중2상
- GSK Investigational Site, Bridgeton · 15마일 거리
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
피험자 모집 중3상
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- 외 4개
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
피험자 모집 중3상
- Research Site, St Louis
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
피험자 모집 중2상
- Washington University School of Medicine, St Louis
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
피험자 모집 중
- Washington University School of Medicine, St Louis
Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma
피험자 모집 중1상
- Washington University School of Medicine, St Louis
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
피험자 모집 중3상
- Saint Louis Cancer and Breast Institute-South City, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- 외 5개
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중1상
- Washington University /ID# 266972, St Louis
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
피험자 모집 중3상
- Saint Louis University, St Louis
Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
피험자 모집 중1상
- Washington University School of Medicine, St Louis
다른 도시의 다발성 골수종 시험
- New York City, NY연구 59개
- Boston, MA연구 45개
- Atlanta, GA연구 42개
- Houston, TX연구 39개
- Durham, NC연구 36개
- Nashville, TN연구 31개
- Denver, CO연구 26개
- Rochester, MN연구 25개
- Columbus, OH연구 25개
- Chicago, IL연구 24개
- Milwaukee, WI연구 23개
- Baldwin Park, CA연구 23개
St. Louis의 다른 연구
- 비소세포폐암연구 68개
- 유방암연구 63개
- 전이성 암연구 52개
- 암 (전체)연구 51개
- 대장직장암연구 51개
- 전립선암연구 45개
- 난소암연구 37개
- 폐암연구 37개
- 췌장암연구 33개
- 두경부 편평세포암연구 32개
- 자궁내막암연구 29개
- 비만연구 25개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.